Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions

Background: The incorporation of genomic testing into clinical practice constitutes an opportunity to improve patients’ lives, as it makes possible the implementation of innovative, individualized clinical interventions that maximize efficacy and/or minimize the risk of adverse drug reactions. In or...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeonidis, Stavros, Koutsilieri, Stefania, Vozikis, Athanassios, Cooper, David N., Mitropoulou, Christina, Patrinos, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688623/
https://www.ncbi.nlm.nih.gov/pubmed/31427963
http://dx.doi.org/10.3389/fphar.2019.00830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688623/
https://www.ncbi.nlm.nih.gov/pubmed/31427963
http://dx.doi.org/10.3389/fphar.2019.00830

Ejemplares similares